Topical Collection on Pharmacology and Pharmacodynamics of Antifungal Agents

ISSN: 1936-3761 (Print) 1936-377X (Online)

In this topical collection (22 articles)

previous disabled Page of 2

  1. No Access

    Pharmacology and Pharmacodynamics of Antifungal Agents

    Antifungal Dosing Considerations in Patients Undergoing Continuous Renal Replacement Therapy

    C. Roger, M. Sasso, J. Y. Lefrant, L. Muller Pages 1-11

  2. No Access

    Pharmacology and Pharmacodynamics of Antifungal Agents (N Beyda, Section Editor)

    Antifungal Dosing Strategies for Critically Ill Patients

    Tyson E. Dietrich, Carolyn J. Pfeifer, Kelsey E. Aker… Pages 5-15

  3. No Access

    Pharmacology and Pharmacodynamics of Antifungal Agents (N Beyda, Section Editor)

    Dosing Antifungals in Obesity: a Literature Review

    Jarrett R. Amsden, Douglas Slain Pages 21-32

  4. No Access

    Pharmacology and Pharmacodynamics of Antifungal Agents (P Gubbins, Section Editor)

    Antifungal Penetration into the Nail and New Topicals for Onychomycosis

    Lindsey M. Childs-Kean, Jacqueline Jourjy Pages 24-29

  5. No Access

    Pharmacology and Pharmacodynamics of Antifungal Agents (P Gubbins, Section Editor)

    Delivery of Antifungal Agents from Bone Cement

    Kelly M. Percival, Jeffery T. Brock, Nathan D. Peterson Pages 30-36

  6. No Access

    Pharmacology and Pharmacodynamics of Antifungal Agents (J Amsden, Section Editor)

    Combination Therapy for Invasive Fungal Infections

    Spencer J. Livengood, Richard H. Drew, John R. Perfect Pages 40-49

  7. No Access

    Pharmacology and Pharmacodynamics of Antifungal Agents (N Beyda, Section Editor)

    Updates in Ocular Antifungal Pharmacotherapy: Formulation and Clinical Perspectives

    Ruchi Thakkar, Akash Patil, Tabish Mehraj… Pages 45-58

  8. No Access

    Pharmacology and Pharmacodynamics of Antifungal Agents (J Amsden, Section Editor)

    Extrapolating Antifungal Animal Data to Humans—Is It Reliable?

    Victoria M. Stevens, Scott W. Mueller, Paul M. Reynolds… Pages 50-62

  9. No Access

    Pharmacology and Pharmacodynamics of Antifungal Agents (J Amsden, Section Editor)

    Applying Pharmacogenomics to Antifungal Selection and Dosing: Are We There Yet?

    Matthew A. Miller, Yee Ming Lee Pages 63-75

  10. No Access

    Pharmacology and Pharmacodynamics of Antifungal Agents (P Gubbins, Section Editor)

    Therapeutic Drug Monitoring and Genotypic Screening in the Clinical Use of Voriconazole

    Brad Moriyama, Sameer Kadri, Stacey A. Henning… Pages 74-87

  11. No Access

    Pharmacology and Pharmacodynamics of Antifungal Agents (P Gubbins, Section Editor)

    The Eagle-Like Effect of the Echinocandins: Is It Relevant for Clinical Decisions?

    Kayla R. Stover, John D. Cleary Pages 88-93

  12. No Access

    Pharmacology and Pharmacodynamics of Antifungal Agents (P Gubbins, Section Editor)

    Combination Therapy for the Treatment of Mucormycosis: Examining the Evidence

    Angela M. Huang, Jerod L. Nagel, Ryan L. Crass… Pages 94-110

  13. No Access

    Pharmacology and Pharmacodynamics of Antifungal Agents (P Gubbins, Section Editor)

    Fungal Biomarkers, Antifungal Susceptibility Testing, and Therapeutic Drug Monitoring—Practical Applications for the Clinician in a Tertiary Care Center

    Jarrett R. Amsden Pages 111-121

  14. Pharmacology and Pharmacodynamics of Antifungal Agents (P Gubbins, Section Editor)

    Fundament and Prerequisites for the Application of an Antifungal TDM Service

    Roger J. M. Brüggemann, Rob E. Aarnoutse Pages 122-129
    Download PDF (288KB) View Article

  15. No Access

    Pharmacology and Pharmacodynamics of Antifungal Agents (J Amsden, Section Editor)

    Antifungal and Oral Anticancer Therapy Drug Interactions

    Chelsea Gustafson, Molly Koslosky, Jill Leslie… Pages 130-140

  16. No Access

    Pharmacology and Pharmacodynamics of Antifungal Agents (J Amsden, Section Editor)

    Azole-Resistant Aspergillus and Echinocandin-Resistant Candida: What Are the Treatment Options?

    Alison R. Novak, Mary E. Bradley, Tyree H. Kiser… Pages 141-152

  17. No Access

    Pharmacology and Pharmacodynamics of Antifungal Agents (J Amsden, Section Editor)

    Updates in the Treatment of Breakthrough Mold Infections

    Kellie J. Goodlet, Kelsey Spadafora, Rajat Walia… Pages 153-165

  18. No Access

    Pharmacology and Pharmacodynamics of Antifungal Agents (P Gubbins, Section Editor)

    The Clinical Significance of Azole Antifungals’ Effects on the Liver and Transaminase Levels

    Viktorija O. Barr, Elizabeth G. Zdyb… Pages 190-195

  19. No Access

    Pharmacology and Pharmacodynamics of Antifungal Agents (J Amsden,, Section Editor)

    Implications of Evolving and Emerging Pharmacokinetic-Pharmacodynamic Research for Triazoles and Echinocandins

    Jason M. Cota, Stephanie E. Giancola… Pages 258-267

  20. No Access

    Invited Commentary

    Review of the Current Management of Urinary Tract Infections due to Fluconazole-Resistant and Non-Albicans Candida Species

    X. Tan, K. Baugh, Z. P. Bulman, E. Wenzler Pages 268-278
previous disabled Page of 2